Clinical research of autologous hematopoietic stem cell transplantation for hematological malignancies and solid tumors.

被引：0
|
作者：
Huang, ZQ [1 ]
Zhang, DH [1 ]
Tan, H [1 ]
Zhou, CZ [1 ]
Liu, D [1 ]
Zhang, HZ [1 ]
Zhang, JX [1 ]
Huang, W [1 ]
Liu, WL [1 ]
机构：
[1] Guangzhou Med Coll, Affiliated Hosp 1, Ctr Oncol & Hematol, Guangzhou, Guangdong, Peoples R China
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.5475.5475
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5475
引用
收藏
页码：456B / 456B
页数：1
相关论文
共 50 条
  • [21] Hematopoietic reconstitution on the prognosis of hematological malignancies after allogenceic hematopoietic stem cell transplantation
    张燕
    ChinaMedicalAbstracts(InternalMedicine), 2012, 29 (04) : 235 - 236
  • [22] Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies
    Arslan, Onder
    Elcin, Ayse Eser
    Atilla, Erden
    Seker, Sukran
    Baydin, Pinar
    Gunduz, Mehmet
    Ozen, Mehmet
    Bayraktar, Ulas Darda
    Ilhan, Osman
    Beksac, Meral
    Elcin, Yasar Murat
    Gurman, Gunhan
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S152 - S153
  • [23] CD34(+)-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience
    Nachbaur, D
    Fink, FM
    Nussbaumer, W
    Gachter, A
    Kropshofer, G
    Ludescher, C
    Niederwieser, D
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 827 - 834
  • [24] CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience
    D Nachbaur
    F-M Fink
    W Nussbaumer
    A Gächter
    G Kropshofer
    C Ludescher
    D Niederwieser
    Bone Marrow Transplantation, 1997, 20 : 827 - 834
  • [25] The Impact of Sarcopenia Regarding Hematopoietic Stem Cell Transplantation for Hematologic Malignancies and Solid Tumors in Childhood
    Suzuki, Daisuke
    Kobayashi, Ryoji
    Matsushima, Satoru
    Hori, Daiki
    Yanagi, Masato
    Kodama, Koya
    Kobayashi, Kunihiko
    PEDIATRIC BLOOD & CANCER, 2020, 67
  • [26] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES - THE ITALIAN EXPERIENCE
    IACONE, A
    DRAGANI, A
    FIORITONI, G
    QUAGLIETTA, A
    DANTONIO, D
    MONTUORO, A
    DEROSA, L
    SCIME, R
    MAJOLINO, I
    MENICHELLA, G
    PIERELLI, L
    DELAURENZI, A
    BONE MARROW TRANSPLANTATION, 1990, 5 : 46 - 47
  • [27] Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignancies
    Robertson, MJ
    Pelloso, D
    Abonour, R
    Hromas, RA
    Nelson, RP
    Wood, L
    Cornetta, K
    CLINICAL CANCER RESEARCH, 2002, 8 (11) : 3383 - 3393
  • [28] AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES
    TEOFILI, L
    SICA, S
    PIERELLI, L
    MENICHELLA, G
    PAOLONI, A
    LEONE, G
    BIZZI, B
    HAEMATOLOGICA, 1990, 75 : 70 - 73
  • [29] An analysis of double autologous hemopoietic stem cell transplantation for hematological malignancies.
    Zhang, BL
    Huang, WR
    Yao, SQ
    Da, WM
    BLOOD, 2000, 96 (11) : 376B - 376B
  • [30] Evaluation of hematopoietic recovery after autologous stem cell transplant in patients with hematological malignancies
    Pinto, Ricardo
    Bordalo, Filipa
    Ferreira, Sara
    Pinho, Catarina
    Lopes, Sergio
    Amado, Fatima
    Salselas, Ana
    Roncon, Susana
    BONE MARROW TRANSPLANTATION, 2018, 53 : 795 - 795
12345